Income Taxes	9 Months Ended
Sep. 30, 2012
Income Taxes [Abstract]
Income Taxes	Note 11 Income Taxes: The Company's effective tax rate is dependent upon the geographic distribution of its earnings or losses (mainly between US and Israel). The difference between the Company's effective tax rates for the three and nine month periods ended September 30, 2012 and the U.S. Federal statutory rate (34%) resulted primarily from Pre-merged PhotoMedex current operations which have generated losses, which reduced the overall corporate tax expense and which will have effect on current tax expense when the Company elects to file a U.S. consolidated income tax return. In addition, the Company recorded a receivable for federal taxes paid in 2010 due to the expected carry back of the Company's 2011 net operating loss for a refund of the 2010 taxes paid by our subsidiary Radiancy, Inc. The receivable is net of alternative minimum tax that is residual to 2010. In addition, the Israeli and UK subsidiaries' earnings are taxed at rates lower than the federal statutory rate (generally 16% to 26%, respectively). The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and can be ambiguous; the Company is, therefore, obliged to make many subjective assumptions and judgments regarding the application of such laws and regulations to its facts and circumstances. In addition, interpretations of and guidance surrounding income tax laws and regulations are subject to change over time. Any changes in the Company's subjective assumptions and judgments could materially affect amounts recognized in its consolidated balance sheets and statements of income. The Company continues to examine the usability of the loss carryforwards from Pre-merged PhotoMedex and the effect of income taxes on the recording of the reverse acquisition on December 13, 2011. For related discussion, see Note 2, Reverse Acquisition and Note 6, Goodwill and Other Intangibles.

Income Taxes

9 Months Ended

Sep. 30, 2012

Note 11

Income Taxes:

The Company's effective tax rate is dependent upon the geographic distribution of its earnings or losses (mainly between US and Israel).

The difference between the Company's effective tax rates for the three and nine month periods ended September 30, 2012 and the U.S. Federal statutory rate (34%) resulted primarily from Pre-merged PhotoMedex current operations which have generated losses, which reduced the overall corporate tax expense and which will have effect on current tax expense when the Company elects to file a U.S. consolidated income tax return. In addition, the Company recorded a receivable for federal taxes paid in 2010 due to the expected carry back of the Company's 2011 net operating loss for a refund of the 2010 taxes paid by our subsidiary Radiancy, Inc. The receivable is net of alternative minimum tax that is residual to 2010. In addition, the Israeli and UK subsidiaries' earnings are taxed at rates lower than the federal statutory rate (generally 16% to 26%, respectively).

The application of income tax law is inherently complex. Laws and regulations in this area are voluminous and can be ambiguous; the Company is, therefore, obliged to make many subjective assumptions and judgments regarding the application of such laws and regulations to its facts and circumstances. In addition, interpretations of and guidance surrounding income tax laws and regulations are subject to change over time. Any changes in the Company's subjective assumptions and judgments could materially affect amounts recognized in its consolidated balance sheets and statements of income.

The Company continues to examine the usability of the loss carryforwards from Pre-merged PhotoMedex and the effect of income taxes on the recording of the reverse acquisition on December 13, 2011. For related discussion, see Note 2, Reverse Acquisition and Note 6, Goodwill and Other Intangibles.